Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular immunity in inflammatory autoimmune neuropathies.

M Mäurer1, K V Toyka, R Gold

  • 1Department of Neurology, Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Julius-Maximilians-Universität Würzburg, Germany.

Revue Neurologique
|April 15, 2003
PubMed
Summary

Autoimmune demyelinating neuropathies involve peripheral nerve inflammation and damage. Cellular immunity plays a key role, offering potential new therapeutic targets for conditions like Guillain-Barré syndrome and CIDP.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New concepts in immunotherapy.

Immunology today·2014
Same author

Histocompatibility antigens and chemical reactivity in autoimmunity.

Immunology today·2014
Same author

Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy.

Experimental neurology·2013
Same author

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.

Neurology·2012
Same author

Ciliary neurotrophic factor (CNTF): physiological and pharmacological effects.

Restorative neurology and neuroscience·2011
Same author

[Multiple sclerosis: updates on pathogenesis and treatment: report from the 9th MS Symposium held by the German Multiple Sclerosis Society].

Der Nervenarzt·2011

Area of Science:

  • Neuroimmunology
  • Peripheral Nervous System Disorders

Background:

  • Autoimmune demyelinating neuropathies, including Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), involve peripheral nerve inflammation and demyelination.
  • Therapeutic responses to plasma exchange and IVIg suggest a significant role for humoral factors in these peripheral nervous system (PNS) autoimmune diseases.

Purpose of the Study:

  • To summarize current knowledge on cellular immunity in autoimmune demyelinating disorders of the PNS.
  • To highlight the relevance of cellular immunity in understanding and potentially treating these conditions.

Main Methods:

  • Review of existing literature on cellular immunity in experimental autoimmune neuritis (EAN) and human autoimmune demyelinating neuropathies.
  • Analysis of the roles of T-cells, macrophages, and cytokines in disease pathogenesis.

Related Experiment Videos

Main Results:

  • Experimental autoimmune neuritis (EAN) serves as a valuable model for understanding human autoimmune neuropathies.
  • Cellular immune mechanisms, including T-cell and macrophage activation and cytokine production, are crucial in these disorders.
  • The study links findings from EAN models to human autoimmune demyelinating neuropathies.

Conclusions:

  • Cellular immunity is integral to the pathogenesis of autoimmune demyelinating neuropathies.
  • A deeper understanding of cellular immunoregulatory mechanisms is essential for developing novel therapeutic strategies.
  • Targeting cellular immunity may offer new avenues for treating GBS, CIDP, and related PNS disorders.